PHAS

PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS

Overview Fund Activity
Delisted

PHAS was delisted on the 2nd of November, 2022.

Back to rankings

61 hedge funds and large institutions have $95.8M invested in PhaseBio Pharmaceuticals, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 15 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
61
Holders Change
+6
Holders Change %
+10.91%
% of All Funds
1.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
23
Reduced
15
Closed
6
Calls
$97K
Puts
$162K
Net Calls
-$65K
Net Calls Change
-$139K

Top Buyers

1
CS
1
Candriam SCA
Luxembourg
$3.36M
2
EP
2
Eversept Partners
New York
$933K
3
CCM
3
CAAS Capital Management
New York
$818K
4
Marshall Wace
4
Marshall Wace
United Kingdom
$681K
5
O
5
OrbiMed
New York
$551K

Top Sellers

1
ECM
1
Endurant Capital Management
California
$3.52M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$12.5M
3
GCP
3
GSA Capital Partners
United Kingdom
$0
4
TEE
4
Tibra Equities Europe
United Kingdom
$0
5
E
5
Ergoteles
New York
$34K
Name Holding Trade Value Shares
Change 		Shares
Change %
State Street
26
State Street
Massachusetts
$246K – – –
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
$244K +$189K +60,873 +344%
Northern Trust
28
Northern Trust
Illinois
$195K -$5.52K -1,775 -3%
JF
29
Jump Financial
Illinois
$136K +$136K +43,867 New
BFM
30
Boothbay Fund Management
New York
$127K +$508 +163 +0.4%
Barclays
31
Barclays
United Kingdom
$101K -$3.55K -1,147 -3%
Jacobs Levy Equity Management
32
Jacobs Levy Equity Management
New Jersey
$97K +$97K +31,324 New
Goldman Sachs
33
Goldman Sachs
New York
$95K -$64.2K -20,681 -40%
OQS
34
Occudo Quantitative Strategies
Florida
$92K +$45.4K +14,533 +97%
PVI
35
Pura Vida Investments
New York
$87K +$87K +27,944 New
HF
36
HRT Financial
New York
$87K +$87K +28,286 New
Squarepoint
37
Squarepoint
New York
$84K +$19.3K +6,216 +30%
SCA
38
Snowden Capital Advisors
New York
$65.3K +$3.11K +1,000 +5%
William Blair & Company
39
William Blair & Company
Illinois
$56K +$3.11K +1,000 +6%
EMG
40
ETF Managers Group
New Jersey
$54K +$9.41K +2,993 +21%
Citadel Advisors
41
Citadel Advisors
Florida
$43K -$81.9K -26,477 -66%
CSS
42
Cubist Systematic Strategies
Connecticut
$41K -$18.7K -5,995 -31%
Acadian Asset Management
43
Acadian Asset Management
Massachusetts
$39K +$39K +12,550 New
XT
44
XTX Topco
Cayman Islands
$35K +$35K +11,215 New
E
45
Ergoteles
New York
$34K -$184K -58,919 -84%
Wells Fargo
46
Wells Fargo
California
$33K +$27.4K +8,793 +487%
TRCT
47
Tower Research Capital (TRC)
New York
$26K +$14.6K +4,557 +128%
Bank of America
48
Bank of America
North Carolina
$17K -$4.85K -1,569 -22%
Osaic Holdings
49
Osaic Holdings
Arizona
$12K +$3.14K +1,000 +35%
CAGAS
50
Capital Advisory Group Advisory Services
Minnesota
$9K – – –
1
2
3